GSK plc (GSK)

Overview Products Trials

Market Cap	$71.40B
Revenue TTM
Earnings Date	2025-02-05
Website	https://www.gsk.com

Upcoming PDUFA Dates

No upcoming PDUFAs found

Upcoming Trial Readouts

Feature coming soon

Upcoming Patent Expirations

Brand Name	Patent Number	Expire Date
ANORO ELLIPTA	7498440	4/27/2025
ANORO ELLIPTA	8309572	4/27/2025
INCRUSE ELLIPTA	7498440	4/27/2025
INCRUSE ELLIPTA	8309572	4/27/2025
TRELEGY ELLIPTA	7498440	4/27/2025
TRELEGY ELLIPTA	8309572	4/27/2025
ANORO ELLIPTA	7439393	5/21/2025
BREO ELLIPTA	7439393	5/21/2025
TRELEGY ELLIPTA	7439393	5/21/2025
ANORO ELLIPTA	8183257	7/27/2025
INCRUSE ELLIPTA	8183257	7/27/2025
TRELEGY ELLIPTA	8183257	7/27/2025
ANORO ELLIPTA	7439393*PED	11/21/2025
BREO ELLIPTA	7439393*PED	11/21/2025
TRELEGY ELLIPTA	7439393*PED	11/21/2025
FLOVENT HFA	7500444	2/26/2026
FLOVENT HFA	7500444*PED	8/26/2026
ANORO ELLIPTA	8511304	6/14/2027
BREO ELLIPTA	8511304	6/14/2027
TRELEGY ELLIPTA	8511304	6/14/2027
JESDUVROQ	11643397	6/22/2027
JESDUVROQ	8557834	6/22/2027
JESDUVROQ	8815884	6/22/2027
ZEJULA	8071579	8/12/2027
ZEJULA	8143241	8/12/2027
ZEJULA	8071579	8/12/2027
ZEJULA	8143241	8/12/2027
ANORO ELLIPTA	9333310	10/2/2027
BREO ELLIPTA	9333310	10/2/2027
INCRUSE ELLIPTA	9333310	10/2/2027
ARNUITY ELLIPTA	9333310	10/2/2027
TRELEGY ELLIPTA	9333310	10/2/2027
ANORO ELLIPTA	8511304*PED	12/14/2027
BREO ELLIPTA	8511304*PED	12/14/2027
TRELEGY ELLIPTA	8511304*PED	12/14/2027
ANORO ELLIPTA	7488827	12/18/2027
INCRUSE ELLIPTA	7488827	12/18/2027
TRELEGY ELLIPTA	7488827	12/18/2027
ANORO ELLIPTA	8161968	2/5/2028
BREO ELLIPTA	8161968	2/5/2028
TRELEGY ELLIPTA	8161968	2/5/2028
ANORO ELLIPTA	9333310*PED	4/2/2028
BREO ELLIPTA	9333310*PED	4/2/2028
ARNUITY ELLIPTA	9333310*PED	4/2/2028
TRELEGY ELLIPTA	9333310*PED	4/2/2028
LAMICTAL XR	8637512	6/14/2028
ANORO ELLIPTA	8161968*PED	8/5/2028
BREO ELLIPTA	8161968*PED	8/5/2028
TRELEGY ELLIPTA	8161968*PED	8/5/2028
JESDUVROQ	8324208	12/11/2028
INCRUSE ELLIPTA	8201556	2/5/2029
ARNUITY ELLIPTA	8201556	2/5/2029
BREO ELLIPTA	11116721	2/26/2029
ZEJULA	8436185	4/24/2029
ZEJULA	8436185	4/24/2029
BREO ELLIPTA	11116721*PED	8/26/2029
OJJAARA	8486941	1/3/2030
ANORO ELLIPTA	8534281	3/8/2030
BREO ELLIPTA	8534281	3/8/2030
TRELEGY ELLIPTA	8534281	3/8/2030
ANORO ELLIPTA	8534281*PED	9/8/2030
BREO ELLIPTA	8534281*PED	9/8/2030
TRELEGY ELLIPTA	8534281*PED	9/8/2030
ANORO ELLIPTA	8746242	10/11/2030
BREO ELLIPTA	8746242	10/11/2030
INCRUSE ELLIPTA	8746242	10/11/2030
ARNUITY ELLIPTA	8746242	10/11/2030
TRELEGY ELLIPTA	8746242	10/11/2030
ANORO ELLIPTA	11090294	11/29/2030
ANORO ELLIPTA	9750726	11/29/2030
TRELEGY ELLIPTA	11090294	11/29/2030
TRELEGY ELLIPTA	9750726	11/29/2030
ZEJULA	8071623	3/27/2031
ZEJULA	8071623	3/27/2031
ANORO ELLIPTA	8746242*PED	4/11/2031
BREO ELLIPTA	8746242*PED	4/11/2031
ARNUITY ELLIPTA	8746242*PED	4/11/2031
TRELEGY ELLIPTA	8746242*PED	4/11/2031
ZEJULA	8859562	8/4/2031
ZEJULA	8859562	8/4/2031
OJJAARA	9809559	6/11/2035
OJJAARA	RE48285	6/11/2035
JESDUVROQ	11117871	3/13/2038
JESDUVROQ	11649217	3/13/2038
ZEJULA	11091459	3/27/2038
ZEJULA	11673877	3/27/2038
ZEJULA	11091459	3/27/2038
ZEJULA	11673877	3/27/2038
ZEJULA	11730725	1/4/2039
OJJAARA	11963962	12/2/2040